Case Report introduction Dhat syndrome has been described as a culture-bound syndrome of Southeast Asia, characterized by a spectrum of anxio-depressive-somato-cognitive manifestations that are attributed to loss of semen or semen-like substances. [1] Patients with Dhat syndrome are often young males from rural background with poor level of education, harboring sexual myths. [1, 2] Psychiatric comorbidities are high with Dhat syndrome, as found in a recent multicentric study. [3] Dhat syndrome may develop as a primary entity, and other psychiatric comorbidities may develop subsequently as an attribution of semen loss or as independent entities. Similarly, Dhat syndrome may develop on the top of an underlying psychiatric morbidity, where it can be an attribution of the psychiatric illness as well as an association by chance. Here, we describe a patient of obsessive-compulsive disorder (OCD), who developed features suggestive of Dhat syndrome after increment of fluoxetine after obtaining the informed consent. The possible attributes for development of Dhat syndrome were discussed.
to continue medications. During interviews, the patient had given a detailed description of his worries related to semen loss. He had mentioned that when he discussed about loss of semen with his friends earlier, they described about the harmful consequences of semen loss. He had also seen the advertisements of faith healers on the street walls, who described semen loss as a severe illness. These experiences amplified his fear and worry. Past and family histories of the patient were insignificant. There was no history of any medical illness or substance use. The patient had completed his graduation and preparing for competitive examinations. Premorbidly, he was well adjusted to life.
His current mental status examination had revealed anxious affect and worries related to semen loss. Obsession of contamination was present. His attention and concentration was impaired; however, other cognitive parameters (memory, intelligence, and verbal fluency) were intact. His routine hemogram was within normal limits. Urine routine and microscopic examination revealed normal parameters along with 2-4 sperms per high-power field. The patient was psychoeducated regarding the sexual myths associated with loss of semen and possible factors that might have developed/led to loss of semen over the past 1 month. Supportive counseling was done as well as relaxation exercises were explained to him. Dietary modifications were also explained. Same medications were continued considering the improvement of symptoms of OCD on that dose. In follow-up, the patient reported a significant reduction in subjective distress, and his symptoms of OCD were also significantly improved.
discussion
In this case, various factors might attribute to the development of Dhat syndrome. Onset of symptoms of Dhat syndrome in this case temporally correlates with dose increment of fluoxetine. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants due to their less frequent side effects. [4] The commonly reported side effects with SSRIs are gastrointestinal side effects, increase in weight, and sexual side effects, which might lead to treatment nonadherence. [4] The individual, who firmly holds the myths related to semen loss is more likely to develop Dhat syndrome.
Constipation is reported to be a rare phenomenon with SSRIs and still rare with fluoxetine. Retrograde ejaculation is again considered to be rare with fluoxetine in comparison to other SSRIs. [5] Despite the rarity mentioned in the literature, our patient reported constipation after augmentation of dose of fluoxetine and also there is evidence of sperms in urine examination, which might be due to retrograde ejaculation. Ongoing stress (due to illness, study pressure, and medication side effects) might have some role in modulating the ejaculation of semen, as stress activates the adrenergic system and may even cause spontaneous ejaculation, though the phenomenon is rare. [6] These side effects, if at all contributed to passage of semen in urine, are benign and often reversible in nature. Reassurance and conservative measures may be sufficient in management in some cases, like ours. The clinician needs to understand the attributes of Dhat syndrome and adequately addresses them for better treatment outcomes. Patients often blame medications for their symptoms. When the blame goes to medications, there is always a risk of nonadherence to medications, despite the benign nature of the symptoms; hence, duly recognizing the symptoms of the patient and adequately addressing them are essential. The cultural factors and beliefs of the patients also need to be given due emphasis in the management plan for a better outcome.
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